NKT, MAIT and Foxp3+ cells in the regulation of disease progression in Chronic Lymphocytic Leukemia (CLL). (#82)
4:00 PM
Role of SHIP1 in iNKT cell development and functions (#83)
4:00 PM
An NKT cell-activating glycolipid-peptide conjugate vaccine enhances human anti-viral CD8+ T cell responses (#84)
4:00 PM
The critical role of iNKT cells in restricting metastatic tumor growth in the liver (#85)
4:00 PM
The use of nano-LC-nESI-MS for lipid antigen identification. (#86)
4:00 PM
iNKT cells improve human umbilical cord cell engraftment in an NSG model of transplant hematopoiesis (#87)
4:00 PM
Harnessing CD1c-restricted T cells for the immunotherapy of leukemia (#88)
4:00 PM
Antitumor activity of a Th1 biased iNKT agonist (#89)
4:00 PM
MAIT cells are activated and accumulated in the mucosa of ulcerative colitis. (#90)
4:00 PM
Synthesis and antitumour activity of 6''-thio-6''-deoxy-α-galactosylceramide (#91)
4:00 PM
Cytokine signalling in the control of human NKT and MAIT cells (#92)
4:00 PM
iNKT cells control prostate cancer progression by restraining pro-angiogenic tumor infiltrating macrophages (#93)
4:00 PM
Involvement of iNKT cells in the control and prognosis of CLL (#94)
4:00 PM
Human MAIT cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity (#95)
4:00 PM
Plasticity in CD1d-lipid antigen recognition by non-canonical NKT cells (#96)
4:00 PM
RGI-2001 induces pharmacological expansion of donor-derived CD4+Foxp3+ regulatory T cells that reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models. (#97)
4:00 PM
Drugs/Drug analogues modulate MAIT cell function in an MR1-dependent manner (#98)
4:00 PM
Using iNKT cells for development of an anti-fungal vaccine (#99)
4:00 PM
A phase I dose escalation trial of immunisation with autologous dendritic cells pulsed with NY-ESO-1 peptide and α-galactosylceramide in patients with high-risk surgically resected stage II, III or IV melanoma (#100)
4:00 PM
Characterizing professional antigen presenting cells that regulate iNKT cell function (#101)
4:00 PM
Cytokine production by the invariant natural killer T cell lineage is regulated by the transmembrane protein kinase IRE1α (#102)
4:00 PM
Mucosal associated invariant T cells are deficient in human airways diseases (#103)
4:00 PM
MAIT cells in a human model of Salmonella Paratyphi infection (#104)
4:00 PM
Identification of MR1 antigens using mass spectrometry (#105)
4:00 PM
Evaluating Environmental Triggers of Inflammatory Bowel Disease (#107)
4:00 PM
Specific in situ detection of Natural Killer T (NKT) cells. (#108)
4:00 PM
The second endogenous thymic ligand of NKT cells: a-glucosylceramide (#110)
4:00 PM
Structural aspects of antigen recognition by atypical MAIT TCRs (#111)
4:00 PM
Crystal structure of human CD1d-β2m produced by silkworm-baculovirus expression system (#112)
4:00 PM
Lipid antigen in atherosclerosis, aggravation of the disease (#113)
4:00 PM
Thymic Precursors to the MAIT cell lineage (#115)
4:00 PM
Identification of phenotypically and functionally heterogeneous mouse Mucosal Associated Invariant T cells using MR1 tetramers. (#116)
4:00 PM
Adipose γδ T Cells Subset into Two Functionally Discrete Populations (#117)
4:00 PM
Characterisation of phenotypically and functionally heterogeneous human MAIT cell subsets (#119)
4:00 PM
MAIT cells frequency in the synovial fluid of psoriatic arthritis patients correlates with disease activity and show increased IL-17 production (#120)
4:00 PM
Generation of CD1d specific single domain antibodies with distinct functional features (#121)
4:00 PM
Identification of an anti-CD1d single domain antibody that profoundly activates iNKT cells in a unique fashion. (#122)
4:00 PM
Atypical Natural Killer T-cell receptor recognition of CD1d-lipid antigens (#123)
4:00 PM
Characterization of Duodenal Mucosal Associated Invariant T (MAIT) Cells in Human Vibrio cholerae O1 Infection (#126)
4:00 PM
Immunological role of alternatively spliced isoforms of MR1 (#127)
4:00 PM
Aminocyclitol glycosphingolipid mimetics are potent activators of nkt cells (#128)
4:00 PM
The two tales of glycosphingolipids in iNKT cell activation (#130)
4:00 PM
The role of T cells in the immune regulation of Langerhans cell histiocytosis (LCH) (#132)
4:00 PM
Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant NKT cells (#133)
4:00 PM
Identification and characterisation of human CD1-autoreactive T cells using CD1-lipid tetramers (#134)
4:00 PM
Innate iNKT cell sensing of HIV-1 infection in dendritic cells is an early immune detection system inhibited by Nef and Vpu. (#135)
4:00 PM
Recognition of Lipid Antigens by CD1-restricted T cells (#137)
4:00 PM
Identification of CD1b-autoreactive T cells using tetramers (#138)
4:00 PM
α-Galactosylceramide-pulsed Human Dendritic Cells Can Ameliorate Post-Infarct Cardiac Remodeling and Failure in Mice (#139)
4:00 PM
MAIT cells are protective in a DSS-induced colitis in MAIT-rich congenic mouse strain. (#140)
4:00 PM
NKT cell – adipocyte interaction modulate adipose tissue function (#141)
4:00 PM
Mechanisms of brain injury-induced immunosuppression and relationship to the development of infection (#142)
4:00 PM
A Single Nucleotide Polymorphism in Human MR1 is Associated with Expression and Susceptibility to Tuberculosis. (#143)
4:00 PM
A structural investigation into CD1b-autoreactive αβ T-cell receptors (#144)
4:00 PM
Increased IFN-γ Production by Circulating Vδ1 Cells in Patients with Multiple Sclerosis Which is Normalized After Natalizumab Treatment (#145)
4:00 PM
Characterization of MAIT cells in the human oral mucosa (#146)
4:00 PM
The role of the CD8 co-receptor on MAIT cells (#147)
4:00 PM
Structural Recognition of CD1d-restricted Microbial lipid antigen by Type II Natural killer T cells (#148)
4:00 PM
CD62L+ NKT cells have superior in vivo persistence and anti-tumor activity (#149)
4:00 PM
Signalling through SLAM-associated protein enables CD8 T Cell Immune Responses Against Antigen-Presenting B Cells (#150)
4:00 PM
Unusual characteristics of sulfatide-reactive type II NKT cells in the mouse liver (#151)
4:00 PM
Disparate recognition of CD1d presented lipid antigens by canonical and non-canonical NKT TCRs (#152)
4:00 PM
MR1-ligand induced apoptosis and functional impairment of mucosal associated invariant T (MAIT) cells in patients with rheumatoid arthritis and ankylosing spondylitis (#153)
4:00 PM
Public and private T cell receptor repertoires define NKT cell subsets with reactivity to CD1d-α-GalCer (#154)
4:00 PM
Investigating the role of human innate-like lymphocytes in pneumonia pathogenesis (#155)
4:00 PM
Assessment of MAIT cell abundance in tissue in red deer (Cervus elaphus) that are resilient or susceptible to Johne’s disease (#156)
4:00 PM
MAIT cells respond to Type I Interferon in vitro and in vivo in the context of viral infections. (#157)
4:00 PM
Invariant Natural Killer T cells dominate Tregs in controlling arthritis in TNF∆ARE mice (#158)
4:00 PM
Pro-inflammatory Mucosal Associated Invariant T (MAIT) cells are enriched in the airways in human tuberculosis (#159)
4:00 PM
Functional and Structural Studies of a Novel Class of Type I Natural Killer T Cell Stimulators: the Aminocyclitol α-Galactosylceramide Analogues (#160)
4:00 PM